IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 310 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,659 | +15.9% | 36,578 | +4.8% | 0.01% | +10.0% |
| Q2 2023 | $1,432 | +1.7% | 34,903 | -11.4% | 0.01% | +11.1% |
| Q1 2023 | $1,408 | -2.9% | 39,383 | +2.6% | 0.01% | -18.2% |
| Q4 2022 | $1,450 | -99.9% | 38,378 | -8.3% | 0.01% | -15.4% |
| Q3 2022 | $1,851,000 | +146.8% | 41,844 | +106.5% | 0.01% | +160.0% |
| Q2 2022 | $750,000 | -22.8% | 20,265 | -22.7% | 0.01% | 0.0% |
| Q1 2022 | $971,000 | +30.5% | 26,212 | +7.2% | 0.01% | +66.7% |
| Q4 2021 | $744,000 | +12.2% | 24,454 | +23.8% | 0.00% | -25.0% |
| Q3 2021 | $663,000 | -5.2% | 19,760 | +12.8% | 0.00% | 0.0% |
| Q2 2021 | $699,000 | -44.4% | 17,518 | -37.3% | 0.00% | -42.9% |
| Q1 2021 | $1,257,000 | -13.9% | 27,956 | +8.2% | 0.01% | -22.2% |
| Q4 2020 | $1,460,000 | +36.3% | 25,829 | +14.4% | 0.01% | +28.6% |
| Q3 2020 | $1,071,000 | -0.9% | 22,579 | +23.2% | 0.01% | -22.2% |
| Q2 2020 | $1,081,000 | +47.3% | 18,331 | +18.0% | 0.01% | +12.5% |
| Q1 2020 | $734,000 | -84.1% | 15,529 | -79.7% | 0.01% | -77.8% |
| Q4 2019 | $4,613,000 | +389.7% | 76,358 | +385.5% | 0.04% | +350.0% |
| Q3 2019 | $942,000 | -25.0% | 15,729 | -19.5% | 0.01% | -20.0% |
| Q2 2019 | $1,256,000 | +64.8% | 19,543 | +32.2% | 0.01% | +100.0% |
| Q3 2018 | $762,000 | -27.8% | 14,779 | -41.6% | 0.01% | -28.6% |
| Q2 2018 | $1,055,000 | -13.2% | 25,310 | -8.2% | 0.01% | -12.5% |
| Q1 2018 | $1,215,000 | -42.6% | 27,561 | -34.5% | 0.01% | -42.9% |
| Q4 2017 | $2,117,000 | +307.1% | 42,084 | +310.5% | 0.01% | +366.7% |
| Q3 2017 | $520,000 | +5.7% | 10,252 | +6.0% | 0.00% | 0.0% |
| Q2 2017 | $492,000 | +27.1% | 9,673 | +0.4% | 0.00% | 0.0% |
| Q1 2017 | $387,000 | -16.4% | 9,630 | -0.6% | 0.00% | 0.0% |
| Q4 2016 | $463,000 | -1.5% | 9,685 | -24.6% | 0.00% | 0.0% |
| Q3 2016 | $470,000 | +135.0% | 12,841 | +49.7% | 0.00% | +200.0% |
| Q2 2016 | $200,000 | -24.5% | 8,577 | +31.1% | 0.00% | -50.0% |
| Q1 2016 | $265,000 | +46.4% | 6,541 | +123.6% | 0.00% | +100.0% |
| Q4 2015 | $181,000 | – | 2,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,463,400 | $418,566,000 | 6.01% |
| Tweedy, Browne Co LLC | 2,722,988 | $120,438,000 | 5.30% |
| BVF INC/IL | 2,872,953 | $127,071,000 | 5.25% |
| Sicart Associates LLC | 253,976 | $11,233,000 | 3.98% |
| Parkman Healthcare Partners LLC | 241,945 | $10,701,000 | 3.04% |
| Camber Capital Management LP | 1,925,000 | $85,143,000 | 2.61% |
| Privium Fund Management B.V. | 148,807 | $6,589,000 | 2.39% |
| SECTOR GAMMA AS | 164,223 | $7,264,000 | 1.87% |
| HANSEATIC MANAGEMENT SERVICES INC | 10,993 | $486,000 | 1.31% |
| BRANDYWINE MANAGERS, LLC | 8,460 | $374,000 | 1.23% |